United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Patrick Poisson, Executive Vice President, Technical Operations, will provide an overview and update ...
Despite many seeing the result as a step backwards, the research community should engage with the new administration with courage, tenacity, strength and unity.
into transplantable HSCs. The findings are published in the journal Proceedings of the National Academy of Sciences. This culture system is notably accessible and versatile, as it does not require ...
Upon its debut, non-reproductive biomedical applications of synthetic embryos were widely touted. For example, synthetic human embryos can serve as experimental models for studying human birth defects ...
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended September 30 ...